Matas Klupšas

Dr. Matas Klupšas

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Open Veterinary Journal
Verified
Journal Article
Open access
PDF file
VSViktoras Sinkevičius
Viktoras Sinkevičius
MKMatas Klupšas
Matas Klupšas
DKDmitrij Kvitka
Dmitrij Kvitka
MJMartinas Jankauskas
Martinas Jankauskas
Background: Legg-Calvé-Perthes Disease (LCPD) is characterized by ischemic necrosis of the femoral head, primarily affecting small breed dogs. Case Description: An 11-month-old, female Toy Poodle presented with hindlimb lameness due to LCPD, previously treated unsuccessfully with NSAIDs. Platelet-Rich Plasma (PRP) was administered intra-articularly. Clinical evaluations included lameness scoring, range of motion (ROM), thigh girth measurements, and radiographic assessment. Conclusion: PRP administration resulted in significant clinical improvement, reduction in lameness, pain relief, cessation of bone lysis, and increased muscle mass by day 44 post-treatment.

12 December 2025 in Animals
Verified
Journal Article
Open access
PDF file
DKDmitrij Kvitka
Dmitrij Kvitka
Martinas JankauskasMartinas Jankauskas
Martinas Jankauskas
MKMatas Klupšas
Matas Klupšas
AGAistė Gradeckienė
Aistė Gradeckienė
DJDalia Juodžentė
Dalia Juodžentė
GRGreta Rudenkovaitė
Greta Rudenkovaitė
Periodontal disease is a progressive inflammatory condition frequently diagnosed in dogs, particularly in small breeds such as Yorkshire Terriers, Toy Terriers, Spitz, Toy Poodles and other breeds predisposed to rapid plaque and tartar accumulation. As the field of regenerative medicine becomes more popular, more and more attention is being paid to substances that promote tissue regeneration, one of which is platelet-rich plasma (PRP). PRP is an autologous blood-derived product rich in growth factors that stimulate tissue regeneration and modulate inflammation. This study aimed to evaluate the clinical effectiveness of PRP injections without additional activating agents in the management of stage 2–3 periodontitis in small-breed dogs. Forty-two adult dogs (Yorkshire Terriers, Toy Terriers, Pomeranians, Toy Poodles, and Havanese) were enrolled and divided into two groups: PRP (n = 30) and control (n = 12). Following standard dental prophylaxis, the PRP group received gingival, submucosal, and periodontal pocket injections of PRP (0.1 mL per site). Periodontitis stage, gingival index, periodontal pocket depth, and horizontal bone loss were evaluated at baseline and 30 days post-treatment. PRP therapy significantly improved all evaluated parameters (p < 0.05). The gingival index decreased threefold, periodontal pocket depth was reduced twofold, and horizontal bone loss decreased by more than twofold compared with baseline and controls. No adverse reactions, discomfort, or postoperative complications were observed. The administration of non-activated PRP as an adjunct to dental cleaning significantly enhances soft and hard tissue regeneration in small-breed dogs with stage 2–3 periodontitis. PRP therapy represents a safe, minimally invasive, and effective regenerative approach for improving periodontal health in routine veterinary dentistry.